Quarterly ResultJun 26, 2026, 04:33 PM
Beyond Air FY26 Revenue +107% to $7.7M; Changes Fiscal Year
AI Summary
Beyond Air, Inc. reported a 107% increase in fiscal year 2026 revenue to $7.7 million, alongside a net loss of $33.2 million. The company announced a change in its fiscal year-end from March 31 to December 31, effective December 31, 2026. Beyond Air also provided revenue guidance of $8 million for calendar year 2026 and $16-$18 million for calendar year 2027, anticipating significant growth driven by its second-generation LungFit PH system, which is currently under FDA review.
Key Highlights
- Fiscal year 2026 revenue increased 107% to $7.7 million.
- Fiscal year 2026 net loss was $33.2 million, or $4.01 per share.
- Board approved change in fiscal year-end from March 31 to December 31, effective Dec 31, 2026.
- Calendar year 2026 revenue guidance is $8 million, representing 15% growth.
- Calendar year 2027 revenue guidance is $16-$18 million, over 110% growth.
- Board approved a 1-for-20 reverse stock split to regain Nasdaq compliance.
- Cash, cash equivalents, and marketable securities totaled $17.3 million as of March 31, 2026.
- Second-generation LungFit PH is under FDA review, potentially expanding US market to $400 million.
Price Impact
More from XAIR